This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Chinese Hepatitis B Vaccine Industry - Deep Research Report 2013





DUBLIN, Nov. 26, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/vjp9tg/2013_deep) has announced the addition of the "Chinese Hepatitis B Vaccine Industry - Deep Research Report 2013" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This 2013 Deep Research Report is a professional and in-depth research report on the Chinese Hepatitis B Vaccine industry. This report firstly discusses Hepatitis B vaccine definition, classification, industry chain, manufacturing technology and product specifications. The report then gives statistics on major Chinese Hepatitis B vaccine manufacturers including details on capacity, production, supply, demand, shortage, selling price, cost, gross margin and production value. The report gives information on 8 Chinese manufacturers such as basic company information, production price, cost, gross margin, production value and Chinese market share. In the end, this report discusses the 10million pieces/year Hepatitis B vaccine project feasibility analysis and investment return analysis, and gives related research conclusions and development trend analysis. Key Topics Covered: 1 Hepatitis B Vaccine Industry Overview 1.1 Definition 1.2 Classification Application Work Principle and Related Content 1.3 Industry Chain Structure 1.4 Market Status and Development Trend 1.5 Policy Analysis 2 Hepatitis B Vaccine Manufacturing Process and Cost Analysis 2.1 Product Speficiation 2.2 Manufacturing Process Analysis 2.3 Cost Structure Analysis 2.4 Raw Materials and Equipments Overview 2.5 Technical Trend and Difficulties 3 Hepatitis B Vaccine Production Supply Sales Demand Market Status and Forecast 3.1 Hepatitis B Vaccine Capacity and Production 3.2 Hepatitis B Vaccine Different Type(Saccharomyces Cerevisiae:5ug 10ug 20ug 60ug,CHO Cell:10ug 20ug,Hansenula Polymorpha:10ug) Capacity and Production 3.3 Children Adult Type Hepatitis B Vaccine Production Overview 3.4 Beijing Shenzhen Liaoning Hebei Shandong Henan etc Different Regions Hepatitis B Vaccine Production Overview 3.5 Hepatitis B Vaccine Capacity Utilization Rate Analysis 3.6 Hepatitis B Vaccine Demand Overview 3.7 Hepatitis B Vaccine Supply Demand Shortage 3.8 Hepatitis B Vaccine Cost Price Production Value Gross Margin 3.9 Hepatitis B Vaccine Import Export Consumption 3.10 Hepatitis B Vaccine Batch Release Number Statistics 4 Hepatitis B Vaccine Key Manufacturers 4.1 Beijing Tiantan Biological Products Co.,Ltd (600161) 4.2 Shenzhen Kaitai Biological 4.3 Dalian Hissen Biological 4.4 NCPC GeneTech Biotechnology 4.5 Beijing Huaerdun Biotechnology 4.6 Hualan Biological(002007) 4.7 GSK 4.8 Berna Biotech 5 Hepatitis B Vaccine New Project Investment Feasibility Analysis 5.1 Hepatitis B Vaccine New Project SWOT Analysis 5.2 10 Million Pieces/Year Hansenula Polymorpha YeastHepatitis B Vaccine (Type:10ug) Project Investment Feasibility Analysis 6 Hepatitis B Vaccine Industry Research Conclusions

Companies Mentioned

  • Berna Biotech
  • Beijing Huaerdun Biotechnology
  • Beijing Tiantan Biological Products Co.,Ltd (600161)
  • Dalian Hissen Biological
  • GSK
  • Hualan Biological(002007)
  • NCPC GeneTech Biotechnology
  • Shenzhen Kaitai Biological

For more information visit http://www.researchandmarkets.com/research/vjp9tg/2013_deep.

Media Contact:

Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs